1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. SPYGLASS PHARMA INC.
SpyGlass Pharma Inc.
XNAS: SGP
Download real time
24.68 0.27 (1.11%)
52W Low on Apr 07, 2026
51,750.2
XNAS Volume

XNAS 05 May, 2026 1:31 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for SpyGlass Pharma Inc is on 07 May 2026 for the purpose of SpyGlass Pharma Inc Annual General Meeting for 2026 See details


Insider Trading disclosures for SpyGlass Pharma Inc

The latest disclosure was made by Ali Behbahani in SpyGlass Pharma Inc where a trade of 1,370,168 Common Stock done was reported to US exchanges on Feb. 9, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Ali Behbahani Director, Ten Percent Owner 09 Feb 2026 1,370,168 4,359,576 - - Common Stock
Ali Behbahani Director, Ten Percent Owner 09 Feb 2026 1,619,240 1,619,240 - - Common Stock
Ali Behbahani Director, Ten Percent Owner 09 Feb 2026 954,990 0 - - Series A Preferred Stock
Ali Behbahani Director, Ten Percent Owner 09 Feb 2026 737,962 0 - - Series D Preferred Stock
Ali Behbahani Director, Ten Percent Owner 09 Feb 2026 1,370,168 0 - - Series C-2 Preferred Stock
Ali Behbahani Director, Ten Percent Owner 09 Feb 2026 1,370,168 0 - - Series C-1 Preferred Stock
Ali Behbahani Director, Ten Percent Owner 09 Feb 2026 1,619,240 0 - - Series B Preferred Stock
Ali Behbahani Director, Ten Percent Owner 09 Feb 2026 402,273 1,357,263 - - Common Stock
Ali Behbahani Director, Ten Percent Owner 09 Feb 2026 954,990 954,990 - - Common Stock
Ali Behbahani Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 16.00 per share. 09 Feb 2026 937,500 6,035,038 - 16 15,000,000 Common Stock
Ali Behbahani Director, Ten Percent Owner 09 Feb 2026 737,962 5,097,538 - - Common Stock
Ali Behbahani Director, Ten Percent Owner 09 Feb 2026 1,370,168 2,989,408 - - Common Stock
Ali Behbahani Director, Ten Percent Owner 09 Feb 2026 402,273 0 - - Series B Preferred Stock
Geoff Pardo Director Purchase of securities on an exchange or from another person at price $ 16.00 per share. 09 Feb 2026 312,500 2,187,513 - 16 5,000,000 Common Stock
Geoff Pardo Director 09 Feb 2026 1,875,013 0 - - Series D Preferred Stock
Geoff Pardo Director 09 Feb 2026 1,875,013 1,875,013 - 0 Common Stock
Kirk Nielsen Director 09 Feb 2026 1,690,230 0 - - Series B Preferred Stock
Kirk Nielsen Director 09 Feb 2026 359,255 0 - - Series D Preferred Stock
Kirk Nielsen Director 09 Feb 2026 548,067 0 - - Series C-2 Preferred Stock
Kirk Nielsen Director 09 Feb 2026 548,067 0 - - Series C-1 Preferred Stock
Bilal Arshad Khan Director Purchase of securities on an exchange or from another person at price $ 16.00 per share. 09 Feb 2026 115,000 251,427 - 16 1,840,000 Common Stock
Bilal Arshad Khan Director Purchase of securities on an exchange or from another person at price $ 16.00 per share. 09 Feb 2026 20,000 25,450 - 16 320,000 Common Stock
Kirk Nielsen Director 09 Feb 2026 548,067 2,786,364 - - Common Stock
Kirk Nielsen Director 09 Feb 2026 359,255 3,145,619 - - Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 16.00 per share. 09 Feb 2026 165,000 3,310,619 - 16 2,640,000 Common Stock
Kirk Nielsen Director 09 Feb 2026 9,689,922 0 - - Series B Preferred Stock
Kirk Nielsen Director 09 Feb 2026 2,059,573 0 - - Series D Preferred Stock
Kirk Nielsen Director 09 Feb 2026 3,142,015 0 - - Series C-1 Preferred Stock
Kirk Nielsen Director 09 Feb 2026 1,690,230 1,690,230 - - Common Stock
Kirk Nielsen Director 09 Feb 2026 548,067 2,238,297 - - Common Stock
Kirk Nielsen Director 09 Feb 2026 3,142,015 0 - - Series C-2 Preferred Stock
Michael Dybbs Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2026 27,400 27,400 - - Stock Option (right to buy)
Jean-Frederic Viret Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2026 17,500 17,500 - - Stock Option (right to buy)
Ali Behbahani Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2026 27,400 27,400 - - Stock Option (right to buy)
Habib Joseph Dable Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2026 27,400 27,400 - - Stock Option (right to buy)
Elizabeth G. O’Farrell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2026 13,700 13,700 - - Stock Option (right to buy)
Geoff Pardo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2026 27,400 27,400 - - Stock Option (right to buy)
Kirk Nielsen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2026 27,400 27,400 - - Stock Option (right to buy)
Zachary Scheiner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2026 27,400 27,400 - - Stock Option (right to buy)
Bilal Arshad Khan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2026 13,700 13,700 - - Stock Option (right to buy)
Patrick H. Mooney Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2026 300,000 300,000 - - Stock Option (right to buy)
Malik Y. Kahook Director, See remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2026 105,000 105,000 - - Stock Option (right to buy)
James Robert Dennewill Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2026 105,000 105,000 - - Stock Option (right to buy)
Chetan Pratap Pujara Chief R&D Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2026 105,000 105,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters